Legal & General Group’s OncoMed Pharmaceuticals, Inc. OMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | – | Sell |
-5,685
| Closed | -$52K | – | 3472 |
|
|
2017
Q1 | $52K | Sell |
5,685
-99
| -2% | -$906 | ﹤0.01% | 2861 |
|
|
2016
Q4 | $44K | Buy |
5,784
+3,367
| +139% | +$25.6K | ﹤0.01% | 2920 |
|
|
2016
Q3 | $27K | Hold |
2,417
| – | – | ﹤0.01% | 2769 |
|
|
2016
Q2 | $29K | Hold |
2,417
| – | – | ﹤0.01% | 2765 |
|
|
2016
Q1 | $24K | Hold |
2,417
| – | – | ﹤0.01% | 2645 |
|
|
2015
Q4 | $53K | Hold |
2,417
| – | – | ﹤0.01% | 2437 |
|
|
2015
Q3 | $36K | Hold |
2,417
| – | – | ﹤0.01% | 2602 |
|
|
2015
Q2 | $54K | Hold |
2,417
| – | – | ﹤0.01% | 2510 |
|
|
2015
Q1 | $63K | Hold |
2,417
| – | – | ﹤0.01% | 2372 |
|
|
2014
Q4 | $52K | Hold |
2,417
| – | – | ﹤0.01% | 2423 |
|
|
2014
Q3 | $46K | Buy |
+2,417
| New | +$46K | ﹤0.01% | 2442 |
|